Published in J Physiol on December 01, 1987
Altered expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferents following chronic airway inflammation in the rat. J Physiol (2008) 1.21
Responses of slowly and rapidly adapting receptors in the airways of rabbits to changes in the Starling forces. J Physiol (1991) 1.04
Respiratory sensations evoked by activation of bronchopulmonary C-fibers. Respir Physiol Neurobiol (2008) 1.02
Effect of pulmonary venous congestion on respiratory rate in dogs. J Physiol (1989) 0.98
Reflex tracheal contraction during pulmonary venous congestion in the dog. J Physiol (1988) 0.98
Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits. J Physiol (1996) 0.96
Identification of vagal sensory receptors in the rat lung: are there subtypes of slowly adapting receptors? J Physiol (1993) 0.91
Plasmapheresis affects responses of slowly and rapidly adapting airway receptors to pulmonary venous congestion in dogs. J Physiol (1989) 0.88
Morphology of presumptive rapidly adapting receptors in the rat bronchus. J Anat (1990) 0.84
Arachidonic acid products in airway nociceptor activation during acute lung injury. Exp Physiol (2011) 0.79
Mechanisms of dyspnea in healthy subjects. Multidiscip Respir Med (2010) 0.79
Effect of bradykinin on respiratory rate in anaesthetized rabbits; role of rapidly adapting receptors. J Physiol (1993) 0.79
Effect of pulmonary lymphatic obstruction on respiratory rate and airway rapidly adapting receptor activity in rabbits. J Physiol (1994) 0.78
Rapidly adapting receptors in a rabbit model of mitral regurgitation. J Physiol (1999) 0.76
Mechanism of pacemaker induced cough. Br Heart J (1994) 0.76
Effect of pulmonary lymphatic obstruction on rabbit urine flow. J Physiol (1997) 0.75
Lung congestion augments the responses of cells in the rapidly adapting receptor pathway to cigarette smoke in rabbit. J Physiol (1995) 0.75
Receptors in the trachea and bronchi of the cat. J Physiol (1954) 6.58
Vagal sensory receptors and their reflex effects. Physiol Rev (1973) 4.51
Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol (1984) 3.56
Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res (1959) 2.47
Impulse activity in afferent vagal C-fibres with endings in the intrapulmonary airways of dogs. Respir Physiol (1977) 2.17
Pulmonary afferent fibres of small diameter stimulated by capsaicin and by hyperinflation of the lungs. J Physiol (1965) 1.80
Information arising from the tracheobronchial tree of mammals. Physiol Rev (1982) 1.79
Mechanisms by which histamine stimulates rapidly adapting receptors in dog lungs. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.53
The activity of vagal stretch endings during congestion in perfused lungs. J Physiol (1945) 1.51
The activity of lung irritant receptors during pneumothorax, hyperpnoea and pulmonary vascular congestion. J Physiol (1969) 1.48
Location of stretch receptors in the trachea and bronchi of the dog. J Physiol (1976) 1.41
The activity of pulmonary stretch receptors during bronchoconstriction, pulmonary oedema, atelectasis and breathing against a resistance. J Physiol (1961) 1.39
The effects of histamine, acetylcholine and 5-hydroxytryptamine on lung mechanics and irritant receptors in the dog. J Physiol (1979) 1.30
The nature of the atrial receptors responsible for a reflex increase in heart rate in the dog. J Physiol (1979) 1.28
Localization of rapidly adapting receptors in the trachea and main stem bronchus of the dog. Respir Physiol (1978) 1.13
Reflex effects following selective stimulation of J receptors in the cat. J Physiol (1980) 1.12
Distribution of airway resistance with developing pulmonary edema in dogs. J Appl Physiol (1972) 1.10
The activity of pulmonary stretch receptors during congestion of the lungs. Q J Exp Physiol Cogn Med Sci (1958) 1.02
Effects of high-frequency oscillatory ventilation on vagal and phrenic nerve activities. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.00
Responses to inflation of vagal afferents with endings in the lung of dogs. Circ Res (1982) 0.97
The effect of emboli upon intrapulmonary receptors in the cat. Respir Physiol (1976) 0.88
The effect of hypothalamic lesions on the melanocyte-stimulating hormone content and histology of the pars intermedia of the rat pituitary gland. J Physiol (1969) 0.83
Effect of bronchoconstriction on the firing behavior of pulmonary stretch receptors. Respir Physiol (1981) 0.83
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet (2000) 8.01
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ (2001) 5.63
Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med (2000) 5.41
A systematic review of randomized trials of disease management programs in heart failure. Am J Med (2001) 5.38
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61
Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ (1997) 2.23
Acute precipitants of congestive heart failure exacerbations. Arch Intern Med (2001) 2.11
Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J (1999) 1.75
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med (1990) 1.50
Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989) Am J Cardiol (1991) 1.48
Comparative response of male and female patients with coronary artery disease to exercise rehabilitation. Eur Heart J (1984) 1.38
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart J (2001) 1.33
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol (1998) 1.22
Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation (1999) 1.21
Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. Br Med J (Clin Res Ed) (1982) 1.19
The management of congestive heart failure. Postgrad Med J (1997) 1.16
Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy. Chest (1994) 1.15
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. CMAJ (2001) 1.13
The changing clinical profile of coronary artery bypass graft patients, 1970-89. Can J Cardiol (1994) 1.04
A survey of clinician attitudes and management practices in hypertension. J Hum Hypertens (1997) 1.04
Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol (1995) 1.02
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA). Am Heart J (2001) 1.02
Cardiac rehabilitation referral and attendance: not one and the same. Rehabil Nurs (1999) 1.01
Effects of high-frequency oscillatory ventilation on vagal and phrenic nerve activities. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.00
Effect of pulmonary venous congestion on respiratory rate in dogs. J Physiol (1989) 0.98
Reflex tracheal contraction during pulmonary venous congestion in the dog. J Physiol (1988) 0.98
Stimulation of rapidly adapting pulmonary stretch receptors by pulmonary lymphatic obstruction in dogs. Can J Physiol Pharmacol (1988) 0.98
Predicting and explaining cardiac rehabilitation attendance. Can J Cardiol (2001) 0.97
Hypercapnic ventilatory response in patients with and without obstructive sleep apnea: do age, gender, obesity, and daytime PaCO(2) matter? Chest (2000) 0.96
Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction. Circulation (1990) 0.93
Cardiac rehabilitation: the forgotten intervention. Can J Cardiol (1999) 0.93
The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators. J Am Geriatr Soc (1999) 0.93
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother (1999) 0.93
Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part II: Novel techniques and new advances. Sports Med (1999) 0.93
Cardiac output measured by impedance cardiography during maximal exercise tests. Cardiovasc Res (1985) 0.91
Psychosocial components of cardiac recovery and rehabilitation attendance. Heart (2001) 0.90
Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part I: Conventional techniques. Sports Med (1999) 0.90
Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer. Am Rev Respir Dis (1990) 0.89
Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest (1986) 0.89
Use of nonprescription medications by patients with congestive heart failure. Ann Pharmacother (1999) 0.88
A review of impedance cardiography. Heart Lung (1995) 0.85
Aspiration biopsy in the diagnosis of pulmonary disease. Chest (1981) 0.83
Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702. Can J Cardiol (2000) 0.81
The gap between reliable evidence and adoption of therapies. Eur Heart J (1999) 0.80
Cause-specific noncardiac mortality in patients with congestive heart failure--a contemporary Canadian audit. Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol (1996) 0.80
Antiarrhythmic therapies for the prevention of sudden cardiac death. Drugs (1997) 0.80
Effects of the respiratory cycle on cardiac output measurements: reproducibility of data enhanced by timing the thermodilution injections in dogs. Crit Care Med (1981) 0.80
Central sleep apnea and heart failure. N Engl J Med (2000) 0.79
Functional capacity in patients with congestive heart failure. J Card Fail (2000) 0.79
A survey of management practices for isolated systolic hypertension. J Am Geriatr Soc (1997) 0.79
Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90. Can J Cardiol (1992) 0.79
Characteristics of pertechnetate movement across the canine tracheal epithelium. Am Rev Respir Dis (1985) 0.79
Integrating clinical quality improvement strategies with nursing research. West J Nurs Res (2000) 0.79
Effects of positive end-expiratory pressure on oscillated flow rate during high-frequency chest compression. Chest (1998) 0.78
Resistant hypertension: an overview. Can J Cardiol (1996) 0.78
Importance of considering ventricular function when prescribing exercise after acute myocardial infarction. Am J Cardiol (1986) 0.78
Response to upright exercise after myocardial infarction. Cardiovasc Res (1987) 0.78
The diagnosis and management of supraventricular tachycardia by transesophageal cardiac stimulation and recording. Chest (1988) 0.78
Critical review of the approaches to the prevention of sudden death. Am J Cardiol (1993) 0.78
Contemporary utilization of digoxin in patients with atrial fibrillation. Clinical Quality Improvement Network Investigators. Ann Pharmacother (1999) 0.77
Effects of long term resistance training on left ventricular morphology. Can J Cardiol (2000) 0.77
Long-term nitrate use in chronic coronary artery disease: need for a randomized controlled trial. Am Heart J (1999) 0.77
Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantation. Am J Cardiol (1989) 0.77
Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol (1991) 0.77
Coronary artery disease prevention: better management of dyslipidemias required. Can J Cardiol (1997) 0.77
A model for demonstration of reversal of impairment of endothelium-dependent relaxation in the cholesterol-fed rabbit. Can J Physiol Pharmacol (1990) 0.77
Oxygen consumption during sleep: influence of sleep stage and time of night. Sleep (1989) 0.77
Effects of hydraulic circuit training on cardiovascular function. Med Sci Sports Exerc (1989) 0.76
Action of histamine on the rapidly adapting airway receptors in the dog. Can J Physiol Pharmacol (1989) 0.76
Sequential changes in canine pulmonary epithelial and endothelial cell functions after nitrogen dioxide. Am Rev Respir Dis (1990) 0.76
Beta-blockers for congestive heart failure: what is the current consensus? Drugs Aging (2000) 0.76
The response to exercise training and vocational counselling in post myocardial infarction and coronary artery bypass surgery patients. Ir Med J (1980) 0.76
Therapy of angina pectoris with low-dose perhexiline. J Cardiovasc Pharmacol (1981) 0.76
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS). Am Heart J (2000) 0.75
Reflex changes in tracheal smooth muscle tone during high-frequency oscillation. J Appl Physiol (1985) (1990) 0.75
Recent advances in the drug treatment of heart failure. Postgrad Med J (1998) 0.75
Angiotensin converting enzyme genotypes and disease. BMJ (1995) 0.75
Risk prediction after myocardial infarction in the elderly. J Am Coll Cardiol (2001) 0.75
Coronary artery bypass graft surgery: initial therapeutic response. Ir Med J (1981) 0.75
The effects of topical and oral slow-release nitroglycerin on anterior myocardial infarction size assessed by precordial ST segment mapping. Eur J Cardiol (1980) 0.75
Effects of irradiation on canine tracheal epithelium: a physiological and morphological correlate. Exp Lung Res (1987) 0.75
Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system. Can J Cardiol (1996) 0.75
Interaction of left atrial receptors and carotid sinus baroreceptors on heart rate in the dog. Am J Physiol (1985) 0.75
Altered pulmonary epithelial permeability in canine radiation lung injury. J Appl Physiol (1985) (1986) 0.75
Intrathoracic liposarcoma: abnormal regional xenon-133 V/Q study. J Can Assoc Radiol (1982) 0.75
Diphenylhydantoin and pulmonary function. Can J Neurol Sci (1979) 0.75
Immediate postextubation upper airway obstruction by a mucous cast. Crit Care Med (1990) 0.75
Psyllium aspiration causing bronchiolitis: radiographic, high-resolution CT, and pathologic findings. AJR Am J Roentgenol (2000) 0.75
Computerized tomography versus perfusion lung scanning in canine radiation lung injury. Int J Radiat Oncol Biol Phys (1990) 0.75
Hypercapnic ventilation response in patients with lung disease: improved accuracy by correcting for ventilation ability. Respiration (1995) 0.75
The effect of high frequency oscillatory ventilation on pulmonary stretch receptors in the dog. Clin Invest Med (1986) 0.75
Pacing in geriatric patients--clinical experience and cost considerations. Ir Med J (1982) 0.75
Echocardiographic evaluation of left ventricular function in patients showing an antihypertensive and biochemical response to indapamide. Postgrad Med J (1981) 0.75
Lack of effect of diazepam on the ST segment of the electrocardiogram during maximal exercise stress testing in normal subjects. J Cardiovasc Pharmacol (1980) 0.75